Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma firms obliged to make medicines even if unprofitable - Opinion
Man buys medicine with the help of a pharmacy sales person in Chongqing municipality, Southwest China, July 21, 2014. [Photo/IC] AFTER MEDIA REPORTS about a shortage, even in some big hospitals, of mercapatopurinem, a medication used to treat…
Lantern Pharma (LTRN) Q1 2025 Earnings Transcript
Thursday, March 27, 2025 at 4:30 p.m. ET President and CEO — Panna Sharma Chief Financial Officer — David Margrave Need a quote from a Motley Fool analyst? Email [email protected] LP-184 Phase 1a Enrollment -- Over 50 patients have…
Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO Annual Meeting
Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO Annual Meeting First clinical data from the Phase 1/2 TEADES trial of ODM-212 to be presented at ASCO 2026 ODM-212 is an…
India collating inputs on hurdles for pharma exports to 8 Asian countries
India has initiated an exercise to identify and seek resolution for market access issues its drugs and pharmaceuticals face in SAARC countries and Iran. The Foreign Trade (South Asia) Division in the Department of Commerce is collecting inputs on…
Google's $2 Billion Bet to Solve Big Pharma's 10^60 Problem
Don't worry, there's nothing wrong with you. Truth is, nobody can. We're talking about a number with 60 zeros! To put a little perspective on this number, it's more than every atom in the observable universe, and more than every star in every…
Liminatus Pharma Is Trending Overnight - Here's Why LIMN Stock Surged Over 79% In After-Hours Session - L
Liminatus Pharma Inc. (NASDAQ:) shares are trending on Friday. LIMN shares surged 79.34% to $0.34 after the bell on Thursday. The stock of the biopharmaceutical company had experienced an intraday drop of 1.16%, closing at $0.19, according to…
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $4.92 Million in Royalty Pharma PLC $RPRX
Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission…
Stock markets rally in early trade tracking positive trend in global peers, easing oil prices
Benchmark equity indices were trading higher in early trade on Thursday (May 21, 2026), helped by easing oil prices and a sharp rally in global markets amid hopes that the West Asia conflict would end soon. The 30-share BSE Sensex climbed 327.74…
Indian Stock Market Rally: Sensex, Nifty Up Amid Global Optimism, Lower Oil Prices
Indian benchmark equity indices, Sensex and Nifty, surged in early trade, buoyed by a positive global market rally and a significant drop in crude oil prices, as investors anticipate a swift resolution to the West Asia conflict. Indian benchmark…
Lilly's 'triple-G' drug leads to bariatric-surgery levels of weight loss in trial
Eli Lilly reported Thursday that in a late-stage trial, its next-generation obesity drug led to levels of weight loss approaching the effectiveness seen with bariatric surgery, but that there were high rates of side effects and discontinuations…
Cassidy's Loss Is a Win for Rural Americans Who Depend on Successful 340B Drug-Discount Program
Recent Republican primaries have given us a lot to celebrate, as so many establishment candidates have lost to America First ones. One that's caught a lot of attention is the loss of Senator Bill Cassidy of Louisiana, who was such a RINO he could…
Foreign investment in Switzerland slumps
The number of foreign investments in Switzerland shrank by almost a quarter to just 84 projects in 2025, as the consulting firm EY reported on Thursday. US companies – the most important investors – reduced their investments by 7%. In…
5 Best Dividend Stocks Now To Buy For June 2026
A young woman is reviews stocks on her computers at night. The best dividend stocks of June 2026 were screened by analyzing dividend safety, total return context and current macro fit. The current interest rate picture is murkier than most…
GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade) (NASDAQ:GDRX)
Gary Alexander 33.88K Followers I'm upgrading GoodRx to a 'Neutral' rating following its recent Q1 earnings print, which showed a return to subscriber growth. Interest in weight loss medication has provided a boost to specialty-specific…
Inside Incyte's $120 Million AI For Drug Development Deal
In this week's edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure's $7 billion valuation, and more. To get it in your inbox, subscribe here. Genesis Molecular AI's Evan Feinberg (left) and Incyte's…
Receive a Daily briefing on Pharma Industry News
Get Started